British Medical Journal (BMJ) 08/01/2002 By Harvey McConnell
There is no increased risk of endometrial cancer among women following long-term use of continuous combined oestrogen-progestogen hormone replacement therapy.
A five-year trial with continuous hormone replacement therapy (HRT) containing oestradiol 2 mg and norethisterone 1 mg daily, found no association with endometrial hyperplasia or malignancy.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!